A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2019

Year

Sanjay Popat, Alessandra Curioni‐Fontecedro, Varvara Polydoropoulou, Riyaz Shah, Mary O’Brien, A. Pope, P.M. Fisher, James Spicer, A. Roy, David Gilligan,

Annals of Oncology

OncologyPhase Iii TrialClinical TrialsPleural DiseaseEtop 9-15Cancer TreatmentMedicineRadiation OncologyRadiologyHealth Sciences